UNSPSC 51143300: Combination anticonvulsants

This classification denotes combination drugs used to prevent seizures or reduce their severity. Typical combination anticonvulsant constituients are phenobarbital and phenytoin.

UNSPSC 51143300 Combination anticonvulsants is a Class code, but the recent solicitation activity under this code shows a significant scope mismatch: Seminole County, Florida released an IFB (IFB60459723LAS, due July 26, 2023) to procure 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, neither of which falls within the anticonvulsant pharmaceutical category. Naloxone is an opioid antagonist used for overdose reversal, and drug deactivation systems are disposal or neutralization equipment—products unrelated to anticonvulsant therapy. The county's procurement specifies quarterly deliveries to the Seminole County Community Health Building in Sanford, with all shipping and delivery costs included in vendor proposals, and requires bidders to comply with drug-free workplace certification, E-Verify authorization, workers' compensation and general liability insurance, and a three-month probationary termination period. The contract carries a two-year initial term with a one-year renewal option and was potentially funded through FEMA with attendant federal compliance requirements.

The code shows little relevant recent activity aligned with its nominal scope of combination anticonvulsants. The single available record represents a tagging error or category misclassification by the issuing body rather than actual pharmaceutical procurement under the anticonvulsant classification. Business development professionals should verify whether opportunities appearing under this code genuinely require anticonvulsant products before pursuing; the current activity suggests that state and local buying of combination anticonvulsants either is not being captured under this code or is not active in the current posting cycle.